Key result
Asymptomatic reduced ABI linked to ~105% greater MACE risk in acute MI patients.
Why the study?
Low ankle-brachial index without symptoms of peripheral arterial disease had not been established as a prognostic marker in acute myocardial infarction patients.
Does asymptomatic low ABI predict major adverse cardiovascular events in AMI patients without a history of PAD?
Cohort (n=850)
No
Does asymptomatic low ABI predict major adverse cardiovascular events in AMI patients without a history of PAD?
Hazard Ratio: 2.046 (95% CI 1.344–3.144)
Absolute Event Rate: 42.2% vs 15%
p-value: p=0.001
Asymptomatic low ABI (<0.9) is a significant independent predictor of long-term adverse cardiovascular events in patients with acute myocardial infarction without a history of PAD.
May support ABI for prognostication in AMI without known PAD; leaves open prospective validation before practice change.
AIMS: Peripheral arterial disease (PAD) is the well-known risk factor for cardiovascular events. Although low ankle-brachial index (ABI) is recognized as a risk factor in general population, low ABI without any symptoms of PAD has not been established as a prognostic marker in patients with acute myocardial infarction (AMI) yet. The purpose of this retrospective study was to examine whether asymptomatic low ABI was associated with long-term clinical outcomes in AMI patients without treatment history of PAD. METHODS: We included 850 AMI patients without a history of PAD and divided them into the preserved ABI (ABI ≥ 0.9) group (n=760) and the reduced ABI (ABI <0.9) group (n=90) on the basis of the ABI measurement during the hospitalization. The primary endpoint was the major adverse cardiovascular events (MACE) defined as the composite of all-cause death, non-fatal myocardial infarction, and hospitalization for heart failure. RESULTS: During the median follow-up duration of 497 days (Q1: 219 days to Q3: 929 days), a total of 152 MACE were observed. The Kaplan-Meier curves showed that MACE were more frequently observed in the reduced ABI group than in the preserved ABI group (p<0.001). The multivariate COX hazard analysis revealed that reduced ABI was significantly associated with MACE (hazard ratio 2.046, 95% confidence interval 1.344-3.144, p=0.001) after controlling confounding factors. CONCLUSIONS: Reduced ABI was significantly associated with long-term adverse events in AMI patients without a history of PAD. Our results suggest the usefulness of ABI as a prognostic marker in AMI patients irrespective of symptomatic PAD.
No takes yet. Share an insight, caveat, or question.
Ban et al. (2021) conducted a cohort in Acute Myocardial Infarction (n=850). Asymptomatic reduced ankle-brachial index (<0.9) vs. Preserved ankle-brachial index (≥0.9) was evaluated on Major adverse cardiovascular events (MACE) defined as the composite of all-cause death, non-fatal myocardial infarction, and hospitalization for heart failure (HR 2.046, 95% CI 1.344-3.144, p=0.001). Asymptomatic reduced ankle-brachial index (<0.9) was significantly associated with an increased risk of major adverse cardiovascular events (HR 2.046) in patients with acute myocardial infarction.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: